Form 8-K - Current report:
SEC Accession No. 0001140361-25-000296
Filing Date
2025-01-06
Accepted
2025-01-06 07:10:36
Documents
19
Period of Report
2025-01-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20041129x2_8k.htm   iXBRL 8-K 44289
2 EXHIBIT 4.1 ny20041129x2_ex4-1.htm EX-4.1 107859
3 EXHIBIT 4.2 ny20041129x2_ex4-2.htm EX-4.2 107077
4 EXHIBIT 5.1 ny20041129x2_ex5-1.htm EX-5.1 16082
5 EXHIBIT 10.1 ny20041129x2_ex10-1.htm EX-10.1 194152
6 EXHIBIT 99.1 ny20041129x2_ex99-1.htm EX-99.1 15253
10 ny20041129x2ex5-1_image01.jpg GRAPHIC 87668
  Complete submission text file 0001140361-25-000296.txt   862682

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA bngo-20250103.xsd EX-101.SCH 4004
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bngo-20250103_lab.xml EX-101.LAB 21967
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bngo-20250103_pre.xml EX-101.PRE 16059
21 EXTRACTED XBRL INSTANCE DOCUMENT ny20041129x2_8k_htm.xml XML 4234
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 25509032
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)